Moderna or Pfizer booster works better for people vaccinated with J&J, study says


PEOPLE who received Johnson & Johnson’s Covid-19 vaccine may benefit from a booster dose of Pfizer or Moderna, preliminary results of a US study published yesterday showed.

The study, funded by the National Institutes of Health (NIH), was eagerly awaited in the United States because it looked at the possibility of “mixing” vaccines – using a different vaccine than the initial doses for the booster shot – which is not currently allowed in the country.


Effective July 2018, access to full reports will only be available with a subscription. Sign-up now and enjoy one (1) week free access!

Subscribe Now!


Sign up or sign in here to comment.


Comments